Selection of blockbuster announcements
Resume trading and suspend trading
1、$Tencent (00700.HK) $Buy back 450000 shares on January 10, at a cost of about HK $204 million
Tencent bought back 450000 shares at a price of HK $442.6-HK $457, at a cost of about HK $204 million, according to an announcement by the Hong Kong Stock Exchange.
2、$Longfor Group (00960.HK) $Cumulative contract sales in 2021 reached 290.09 billion yuan, an increase of 7.2% over the same period last year
Longfor Group announced that by the end of December 2021, the group had realized a total contract sales of 290.09 billion yuan, an increase of 7.2% over the same period last year; the contract sales area was 17.089 million square meters. In December 2021, the monthly contract sales amount is 39.69 billion yuan, with a contract sales area of 2.521 million square meters.
3、$Qiu Titanium Technology (01478.HK) $45.631 million camera modules were sold in December, an increase of 22.6% over the same period last year
Qiu Ti Technology disclosed sales data of its main products in December 2021, with a total of 45.631 million camera modules sold in that month, an increase of 22.6% over the same period last year. Of this total, 19.793 million camera modules with 8 million pixels and less were sold, up 96.7 percent from the same period last year; and 25.838 million camera modules with 10 million pixels and above were sold, down 4.8 percent from the same period last year. In addition, sales of fingerprint recognition modules totaled 10.588 million, up 2.7 per cent from a year earlier. Of these, 4.474 million pieces of off-screen fingerprint recognition modules were sold, down 1.3% from the same period last year; and 6.114 million pieces of off-screen fingerprint recognition modules were sold, up 5.9% from the same period last year.
4、$Shimao Group (00813.HK) $The borrower under the fund is not a subsidiary and is discussing the sale of the property with the buyer
Shimao Group issued an announcement, with several media reports claiming that the group had not yet fulfilled its financial responsibilities under a fund. The company clarified that the borrower under the fund was not a subsidiary. Two subsidiaries of the Group have provided guarantees for the financial liability of borrowers under the Fund. According to the company, the borrower and the fund are discussing repayment arrangements.
As of the date of this announcement, the company has no asset-backed securities due and payable. The company has not entered into a preliminary agreement for the sale of Shanghai Shimao International Plaza. The company is discussing with a number of potential buyers on the sale of certain properties and will consider selling some of its assets under appropriate conditions to reduce the group's liabilities.
5、$Rehabilitation Medical Technology (01696.HK) $Annual net profit is expected to increase by more than 120%
Fu Rui Medical Technology announced that the company expects earnings for the 12 months ended December 31, 2021 to rise significantly by more than 80% compared with the same period in 2020, and expects profits to increase by more than 120% during that period. The significant increase in expected earnings and profits during the period was mainly attributable to (I) the Group's operations in more than 90 countries and territories around the world, helping to maintain sharpness and flexibility in dynamic markets; (ii) strong growth in three major markets: North America, China and Europe, while earnings in North America doubled year-on-year With strong R & D capability, iii has successfully launched 5 new products and commercialized them in the past two years.
6、$Dalip Holdings (01921.HK) $Successfully entered the list of qualified suppliers of Kuwait Oil Company
Dalip Holdings announced that on January 5, 2022, Dalip Petroleum Special Pipe Co., Ltd., a wholly owned subsidiary of the group, successfully entered the list of qualified suppliers of Kuwait Oil Company. This entry into the list of qualified suppliers of Kuwait Oil Company is a manifestation of the recognition of the quality of the Group's products and services, and lays a solid foundation for the Group's sustainable development in overseas markets, especially in the Middle East.
Important matters
Junshi Bio (01877): Coherus is licensed to develop oncology drug JS006 in the United States and Canada
BeiGene, Ltd. (06160): some drugs or new indications enter the new edition of the national health insurance catalogue.
CSPC Pharmaceutical (01093): the antineoplastic drug "zoledronic acid injection" was registered and approved.
Sino Biopharmaceutical (01177): the developed diabetes drug "sioglitine metformin sustained release tablets" has been approved to go on the market.
Sihuan Medicine (00460): medical skin care gel and repair gel obtained medical device registration certificate
HUTCHMED (China) Limited (00013): start the clinical trial of HMPL-760
Golly Pharmaceutical-B (01672): submit US Clinical trial Application for PD-L1 small molecule Inhibitors
Keji Pharmaceutical-B (02171): FDA awarded CT041 Advanced Therapy qualification in Regenerative Medicine
Stone four Pharmaceutical Group (02005): Sinacasai Hydrochloride has been approved to be registered as an API for use in listed preparations.
Kangfang Bio-B (09926): Ib/II clinical study of Ligufalimab combined with Ivonescimab was approved.
China Water Affairs (00855): cooperation agreement between Hubei sub-quality water supply and ANLU capital investment
Shenzhou International Group (02313): local factories resume production
Baiyunshan (00874) received a government subsidy of about 236 million yuan in the second half of 2021.
Hengteng Network (00136): Tencent computer will provide technical services and channel promotion services to the Group's game products in mainland China.
Financial report data
Medical thinking and Health (02138): sales in the fourth quarter of 2021 grew by no less than 41% year-on-year
Longguang Group (03380): contract sales of 140.2 billion yuan belonging to shareholders' equity in 2021 increased by 16.2% over the same period last year.
Cosco Group (03377): cumulative agreed sales in 2021 increased by 3.98% to 136.26 billion yuan over the same period last year.
Yuzhou Group (01628): cumulative sales of 105.019 billion yuan in 2021
Poly Real Estate Group (00119): contract sales increased by about 8.64% to 56.6 billion yuan in 2021 compared with the same period last year.
Greenland Hong Kong (00337): contract sales of about $33 billion in 2021
Dragonair China Real Estate (06968): contract sales of about 30.041 billion yuan in 2021
Longfor Group (00960): contract sales in 2021 increased by 7.2% year on year to 290.09 billion yuan
Yue Yuen Group (00551): cumulative net operating income of US $8.533 billion in 2021 increased by 1% year on year
Cofco Jiakang (01610): the number of pigs produced in December was 307000, an increase of 14.55% over the previous month.
CGN New Energy (01811): completed generating capacity of 18000 GWh in 2021, an increase of 31.4% over the same period last year.
Repurchase cancellation
Easy bulk (01733): buy back 26.64 million shares with HK $33.7067 million on January 10
Man Wah (01999): repurchase 2.6928 million shares with HK $30.2867 million on January 10th
Tianlun Gas (01600): buy back 2.5 million shares at a cost of about HK $20.862 million on January 10th
Federal Pharmaceutical (03933): HK $3.282 million buyback 744000 shares on January 7
Riqing Food (01475): repurchase 400000 shares with HK $2.5863 million on January 10
Foreign exchange technology (01860): buy back 373000 shares at a cost of about HK $2.5261 million on January 10th
Yongda Motor (03669): buy back 300000 shares at a cost of about HK $2.643 million on January 10th
Net Dragon (00777): buy back 200000 shares at HK $3.5996 million on January 10
Country Garden Services Holdings (06098): repurchase 140000 shares with HK $6.125 million on January 10th
Equity incentive
Heartbeat Company (02400): 5.6759 million share options granted
Fellow hunters (06100): a total of 600000 share options granted
Genscript Biotech Corporation (01548): granting about 164400 restricted shares to rotating CEO Liu Zhenyu
Additional placement
China Southern Airlines (01055): application materials for non-public offering of A shares are accepted by China Securities Regulatory Commission
China has likes (08083): HK $310 million from the completion of the placement is planned to be used for product development and potential strategic investment
Celadon Game (06633): the over-allotment option is partially exercised and the stable price period ends.
Xiansheng Pharmaceutical (02096): issued 11.841 million shares under the restricted share unit plan on January 10th
Yonghe Medical (02279): 7.1245 million shares were issued due to the partial exercise of the over-allotment option
Listing of new shares
VANOV HOLDINGS (02260) IPO is 13.66 times subscribed and is expected to be listed on January 11.
Resume trading
China Trading Group (01719) will change ownership Hubei Port Group is proposed to receive a 6.5% premium offer to resume trading on the 11th.
Set up a company
Ed Weisuan Group (09919) established a joint venture with Quick Technology to establish a metacosmos marketing company.
Asset sale
Agile Group (03383) sells properties for $2.8 billion
Issuing bonds by bills
China Merchants (06099): complete the issuance of 3 billion yuan of short-term financing bonds
Huaneng International Power Co., Ltd. (00902): complete the issue of 2 billion yuan ultra-short financing
Li-Ning-Hu Expressway (00177): complete the issuance of 500 million yuan of ultra-short-term financing bonds
Hopson Development (00754): complete the issuance of US $250 million of guaranteed convertible bonds
Jinhui Holdings (09993): affiliated repurchase and cancellation of a total of US $142.6 million of 2022 bills
Xuhui holding Group (00884): the company accepts the purchase of bills with a principal amount of US $265 million.
Edit / new